Company: QTIWW
Filing Date: 2025-08-07
Form Type: DEFA14A
Source: 0001844505-25-000081
Chunk: 1

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-08-07
Form: DEFA14A
Chunk 1
---
 are even more energized by the significant opportunities ahead,” said Dr. Raluca Dinu, QT Imaging Chief Executive Officer. “QT Imaging is rapidly evolving from a scanner company into a scalable imaging platform—combining proprietary hardware, advanced image reconstruction software, and AI-powered clinical decision tools to address the growing need for precision in breast health. Our goal is not only to drive greater user adoption of our proprietary, state-of-the-art scanner technology, but also to advance and commercialize a new generation of AI-enhanced diagnostic tools that support earlier detection, enable better categorization and staging, improve outcomes, and broaden access. With eight scanners shipped in Q2 and two more in July under our USA distribution agreement with NXC Imaging, we are building the foundation for broader adoption.

Dr. Dinu continued, “Additionally, we would like to take this opportunity to thank those stockholders who have already voted ahead of our Annual Meeting of stockholders, taking place virtually on August 19. To those who have not yet voted, or abstained, we kindly request that you let your voice be heard by voting now. Increasing the price of our common shares via a reverse stock split is intended to comply with the minimum share price requirement for uplisting to Nasdaq. We hope to have the support of our stockholders as we take this next pivotal step in QT Imaging’s growth."

#### Second Quarter and Recent Business Developments
#### •

Shipped eight QT Imaging Breast Acoustic CT™ scanners and generated record revenue of $3.7 million in the second quarter of 2025, up 31% and 113% from first quarter of 2025 and second quarter of 2024, respectively, and in line with the 2025 annual projections.

• Strengthened financial position via $700,000 in net proceeds from two Private Investment in Public Entity (PIPE) investments; $500,000 fully funded by QT Imaging Board members

*Refer to the “Non-GAAP Financial Measures” section in this press release.

<div align='center'>Page 1</div>

and $200,000 funded by Mr. Leon Recanati, Vice Chairman of the Israel Cancer Association.

• Made the Company’s radiation-free, 3D breast imaging technology available to patients in Iowa for the first time via the delivery and installation of a QTI Breast Acoustic CT™ scanner at Innovative Radiology in West Des Moines.

• Announced QTI’s latest image reconstruction software update release, version 4.4.0, which delivers